Background: Nitric Oxide (NO) is a naturally occurring modulator of inflammation found in the human body. Several studies in the pediatric cardiothoracic surgery literature have demonstrated some beneficial clinical effects when NO is added to the sweep gas of the cardiopulmonary bypass circuit.
Purpose: Our primary aim was to determine the safety of incorporating nitric oxide into the oxygenator sweep gas of the extracorporeal membrane oxygenation (ECMO) circuit. Secondarily, we looked at important clinical outcomes, such as survival, blood product utilization, and common complications related to ECMO.
Methods: We performed a single center, retrospective review of all patients at our institution who received ECMO between January 1, 2017 and March 31, 2023. We began additing NO to the ECMO sweep gas in 2019.
Results: There were no instances of clinically significant methemoglobinemia with the addition of NO to the sweep gas (0% vs 0%, p = 1). The median daily methemoglobin level was higher in those who received NO via the sweep gas when compared to those who did not (1.6 vs 1.1, p = <0.001).
Conclusions: The addition of NO to the sweep gas of the ECMO circuit is safe.
CashenKMeertKDaltonHJ. Platelet count and function during pediatric extracorporeal membrane oxygenation. Semin Thromb Hemost2020; 46(3): 357.
2.
ThomasJKostousovVTeruyaJ. Bleeding and thrombotic complications in the use of extracorporeal membrane oxygenation. Semin Thromb Hemost2018; 44(1): 20.
3.
SchecterANGladwinMT. Hemoglobin and the paracrine and endocrine functions of nitric oxide. N Engl J Med2003; 348: 1483–1485.
4.
VuongTARanaMSMooreB, et al.Association between exogenous nitric oxide given during cardiopulmonary bypass and the incidence of postoperative kidney injury in children. J Cardiothorac Vasc Anesth2022; 36(8 Pt A): 2352–2357.
5.
ChecchiaPABronickiRAMuenzerJT, et al.Nitric oxide delivery during cardiopulmonary bypass reduces postoperative morbidity in children–a randomized trial. J Thorac Cardiovasc Surg2013; 146(3): 530–536.
6.
JamesCMillarJHortonS, et al.Nitric oxide administration during paediatric cardiopulmonary bypass: a randomised controlled trial. Intensive Care Med2016; 42(11): 1744–1752.
7.
SchlapbachLJGibbonsKSHortonSB, et al.Effect of nitric oxide via cardiopulmonary bypass on ventilator-free days in young children undergoing congenital heart disease surgery: the NITRIC randomized clinical trial. JAMA2022; 328(1): 38–47.
8.
MakhoulSWalterEPagelO, et al.Effects of the NO/soluble guanylate cyclase/cGMP system on the functions of human platelets. Nitric Oxide Biol Chem2018; 76: 71–80.
9.
ChilettiRHortonSBednarzA, et al.Safety of nitric oxide added to the ECMO circuit: a pilot study in children. Perfusion2018; 33(1): 74–76.
10.
O’mearaCTimpaJPeekG, et al.Nitric oxide on extracorporeal life support-circuit modifications for a safe therapy. J Extra Corpor Technol2022; 54(2): 142–147.
ShaddyREFullerTC. The sensitized pediatric heart transplant candidate: causes, consequences, and treatment options. Pediatr Transplant2005; 9: 208–214.
13.
FrandsenELAlbersEL. Management of the sensitized pediatric heart transplant patient. Transl Pediatr2019; 8(4): 302–313.
14.
HebertPCWellsGBlajchmanMA, et al.A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in Critical Crae Investigators, Canadian Critical Care Trials Group. N Engl J Med1999; 340(6): 409–417.
15.
KochCGLiLDuncanAL, et al.Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med2006; 34: 1608–1616.
16.
KneyberMCJHersiMITwiskJWR, et al.Red blood cell transfusion in critically ill children is independently associated with increased mortality. Intensive Care Med2007; 33: 1414–1422.
